Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NKTR-358, A Novel Autoimmune Therapy Jul 24, 2017 Nektar Announces Topline Data from Human Abuse Potential Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain Jul 18, 2017 Nektar Presents New Preclinical Data for NKTR-358, a First-in-Class Regulatory T Cell Stimulator, at 13th World Congress of Inflammation in London Jul 10, 2017 Nektar to Webcast Presentation at Jefferies 2017 Global Healthcare Conference in New York City Jun 06, 2017 Nektar Presents New Clinical Data from Two Studies of NKTR-214, a CD122-Biased Agonist, at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting Jun 05, 2017 New Research Collaboration between Nektar and Takeda to Explore Combination Cancer Therapy Approaches with NKTR-214, a CD122-Biased Agonist, and Five Takeda Cancer Therapy Compounds May 22, 2017 Nektar Therapeutics Announces Data Presentations at ASCO 2017 May 18, 2017 Nektar to Webcast Presentation at UBS Global Healthcare Conference 2017 in New York May 15, 2017 Nektar Therapeutics Reports Financial Results for the First Quarter of 2017 May 09, 2017 Nektar Appoints Brian L. Kotzin, M.D. as Head of Clinical Development for Nektar's Immunology Program May 03, 2017 Pagination First page « first Previous page ‹ previous … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 … Next page next › Last page last »